Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Familial association of a variant in MEGF6 with osteoporosis

Oct. 25, 2018

Takeda Pharmaceutical and Scohia Pharma identify free fatty acid FFA1 receptor agonists

Oct. 23, 2018

Nrf2 pathway, novel therapeutic target for the treatment of cognitive impairment in type 1 diabetes

Oct. 19, 2018

NeuroVive drug candidate shows efficacy in model for mitochondrial disease

Oct. 19, 2018

Homology Medicines' gene therapy for PKU shows promising preclinical results

Oct. 19, 2018

Jiangsu HengRui studies SHR-1209 in phase I in China

Oct. 19, 2018

Urocortin 3 is involved in the pathophysiology of diabetes

Oct. 18, 2018

Podocalyxin as a promising new biomarker in women with polycystic ovary syndrome

Oct. 18, 2018

OCLI-070 inhibits osteoclast differentiation in ligature-induced experimental osteolysis

Oct. 17, 2018

Zhejiang Hisun Pharmaceutical Co. patents acetyl-CoA carboxylase inhibitors

Oct. 17, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...